| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.01▼ | 7.00▼ | 6.99▲ | 7.22▼ | 6.90▲ |
| MA10 | 7.01▼ | 6.98▲ | 7.07▼ | 7.07▼ | 7.23▼ |
| MA20 | 7.01▼ | 7.07▼ | 7.04▼ | 6.79▲ | 6.87▲ |
| MA50 | 6.98▲ | 7.11▼ | 7.10▼ | 7.21▼ | 6.32▲ |
| MA100 | 7.06▼ | 7.09▼ | 6.97▲ | 6.79▲ | 7.01▼ |
| MA200 | 7.05▼ | 6.94▲ | 6.83▲ | 6.30▲ | 8.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.003▼ | -0.010▼ | 0.060▲ | -0.019▼ |
| RSI | 47.367▼ | 44.482▼ | 45.163▼ | 50.253▲ | 52.385▲ |
| STOCH | 38.294 | 31.687 | 10.815▼ | 52.578 | 23.591 |
| WILL %R | -95.238▼ | -87.500▼ | -86.420▼ | -50.877 | -72.325 |
| CCI | -118.925▼ | -15.147 | -43.520 | 36.552 | 3.441 |
|
Wednesday, July 08, 2026 04:19 AM
Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the appointment of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/07/26 | 7.25 | 7.3371 | 6.94 | 7.00 | 682,535 |
| 08/07/26 | 7.03 | 7.37 | 6.95 | 7.25 | 1,210,985 |
| 07/07/26 | 7.13 | 7.285 | 6.80 | 7.03 | 814,995 |
| 06/07/26 | 7.74 | 7.87 | 7.06 | 7.09 | 678,027 |
| 02/07/26 | 6.77 | 7.75 | 6.58 | 7.74 | 961,698 |
| 01/07/26 | 7.14 | 7.185 | 6.53 | 6.73 | 680,107 |
| 30/06/26 | 6.90 | 7.29 | 6.81 | 7.10 | 1,261,950 |
| 29/06/26 | 6.95 | 7.20 | 6.82 | 6.88 | 383,195 |
| 26/06/26 | 6.86 | 7.08 | 6.775 | 7.00 | 1,628,001 |
| 25/06/26 | 7.06 | 7.34 | 6.845 | 6.86 | 336,074 |
|
|
||||
|
|
||||
|
|